Navigation Links
Mylan Announces Tentative FDA Approval for Lamotrigine Tablets
Date:12/12/2007

PITTSBURGH, Dec. 12 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced that Mylan Pharmaceuticals Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Lamotrigine Tablets, 25 mg, 100 mg, 150 mg and 200 mg.

Lamotrigine Tablets are the generic version of GlaxoSmithKline's Lamictal(R) Tablets, which had U.S. sales of approximately $1.97 billion for the 12 months ending Sept. 30, 2007.

Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient (API) manufacturers in the world. Dey L.P., Mylan's fully integrated specialty business, provides the Company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas.

For more information about Mylan, please visit http://www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015
2. Mylan to Host Investor Day on October 3, 2007
3. Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
4. Mylan Announces Appointment of Steven G. Zylstra as Vice President of Global Corporate Communication and Public Relations
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
7. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
8. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
9. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
10. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... quantum computing is that it will dramatically ou...ey problems: searching large databases, factoring ...lating the atomic structure of materials. , A qu... pun, has been taken by Stanford researchers who a... journal Nature . Working in the Ginzton Laborato...
(Date:11/21/2008)...Nov. 21 MichBio, the association f...ly 500 biosciences professionals,and service prov...nesday of,this week at the Rock Financial ShowPla...annual gathering of Michigan bioscience industry p...acted 56 exhibitors. The 2009 Expo is,planned for...
(Date:11/21/2008)...OUS FINANCIAL AND RESTRUCTURING ALTERNATIVES ONGOI...Call/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ...al and medical device company, today announced tha... (Ares) and New Leaf Venture Partners (New Leaf) t...e Agreement dated July 7, 2008. Angiotech had anno...
(Date:11/21/2008)... Gen-Probe,s (Nasdaq: ...portant new molecular tool to more,accurately det...s that are,associated with cervical cancer or pre...ations and two scientific posters presented last w...he international conference of the,European Resea...
Breaking Biology Technology:Stanford: Quantum computing spins closer 2MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile 2MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile 3Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 2Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 3Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 4Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 2Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 3Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 4Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 5
...% of mammalian RNA from , complex mix... Simple procedure takes less than 2 hours , ... Seamless integration with , ...Kit , Enables microarray expre...solated from host cells , Ambion,...
...ea Kroenke 1 , Anne , Grabner 1... Latham 2 , and Christophe Echeverri 1 , ..., Inc. , ,... gene class, also called siRNA libraries,... increase the pace of pathway analysis and functio...
...a complete Gene Expression Profiling Service* for ...ta analysis to our Full Service offering, , ...rvice offering includes , consultation with...s scientists , and comprehensive data analy..., , high quality products and services for ...
...A delivery in less time for a fraction of the , ...from one to 96 samples simultaneously , ...ansfection-induced , toxicity , ...cer CellReady , Transfection Optimization... solution , Efficient and reproduc...
Other Biology Technology:Bacterial RNA Isolation From Infected Eukaryotic Hosts 2Bacterial RNA Isolation From Infected Eukaryotic Hosts 3Bacterial RNA Isolation From Infected Eukaryotic Hosts 4Bacterial RNA Isolation From Infected Eukaryotic Hosts 5Bacterial RNA Isolation From Infected Eukaryotic Hosts 6Assessing Gene Function with siRNA Libraries 2Assessing Gene Function with siRNA Libraries 3Assessing Gene Function with siRNA Libraries 4Assessing Gene Function with siRNA Libraries 5Assessing Gene Function with siRNA Libraries 6Assessing Gene Function with siRNA Libraries 7Ambion Offers Gene Expression Profiling Service 2Ambion Offers Gene Expression Profiling Service 3A New Way to Assess siRNA Delivery Efficiency 2A New Way to Assess siRNA Delivery Efficiency 3A New Way to Assess siRNA Delivery Efficiency 4A New Way to Assess siRNA Delivery Efficiency 5
(Date:11/21/2008)... , , , , , , , ... , , , VIDEO: , G...009 AAAS/Science dance contest. She is completing ...ersity of Sydney, Australia. The title of her... ...on. , , , , , , , ...
(Date:11/21/2008)...New Rochelle, NY, November 21, 2008A prestigious g...providers will gather in Williamsburg, VA on March...actical, clinical information on cutting-edge ther...d innovative research advances that impact patient...nd registration information is available at www.b...
(Date:11/21/2008)... ANN ARBOR, Mich.---Slow-moving ocean and river c...ternative energy source. A University of Michigan ... to turn potentially destructive vibrations in flu...ine is called VIVACE. A paper on it is published i...ffshore Mechanics and Arctic Engineering . , VIV...
(Date:11/21/2008)...rdiovascular conditions leading to heart attacks a...n cancers of the prostate, breast or lung, but now...hanisms at the molecular level. This in turn provi...cer and cardiovascular diseases, but requires rese... The seeds were sown for closer cooperation betwee...
Breaking Biology News(10 mins):The 2009 AAAS/Science dance contest winners are announced 2The 2009 AAAS/Science dance contest winners are announced 3The 2009 AAAS/Science dance contest winners are announced 4The 2009 AAAS/Science dance contest winners are announced 5The 2009 AAAS/Science dance contest winners are announced 6The 2009 AAAS/Science dance contest winners are announced 717th Annual Congress on Women's Health convenes 2'Fish technology' draws renewable energy from slow water currents 2'Fish technology' draws renewable energy from slow water currents 3Mechanisms of cardiovascular disease and cancer give clues to new therapies 2Mechanisms of cardiovascular disease and cancer give clues to new therapies 3Bushs Budget Proposal Would Cut Medicare Spending 10991 1Bushs Budget Proposal Would Cut Medicare Spending 10991 2Bushs Budget Proposal Would Cut Medicare Spending 10991 3Bushs Budget Proposal Would Cut Medicare Spending 10991 4DiObex Inc to Present at Merrill Lynch Global Healthcare Conference 3009 1Vasogen to Present at the BIO CEO 26 Investor Conference and Participate on the Non Cancer Immunotherapy Panel 3008 1Vasogen to Present at the BIO CEO 26 Investor Conference and Participate on the Non Cancer Immunotherapy Panel 3008 2Vasogen to Present at the BIO CEO 26 Investor Conference and Participate on the Non Cancer Immunotherapy Panel 3008 3Anthera Pharmaceuticals Forms Scientific Advisory Board 3004 1Anthera Pharmaceuticals Forms Scientific Advisory Board 3004 2
... Though many spring flowers have bright advertisem...mon flowers have not-so-sweet or even toxic nectar...ey wish to attract is a scientific mystery. , The...t least 1/3 of the world’s crop plants, may encoun... plants such as Rhododendrons and almond trees. Ca...
... Fats in our stomach may reduce the protective eff... at the University of Glasgow found that in the pr...as ascorbic acid (the active component of vitamin ... cancer-forming compounds in the stomach is less t...trate how diet can influence gastric biochemistry?...
... To function, each living cell needs both to build...complish that, a number of intracellular systems w...logging up with damaged proteins. When proteins or...to the clearing up of the intracellular environmen...ing mutation in the huntingtin gene eventually cau...
... A new medical device in development by University... disorders that could be an early warning of Alzhe...lems outside the typical sensory loss associated w...ntion of UC Psychology Professor Robert Frank and ...rtment of Cell Biology, is now under further devel...
Other Biology News:Proteasome activator enhances survival of Huntington's disease neuronal model cells 2Get a whiff of this: Smell test could sniff out serious health problems 2Get a whiff of this: Smell test could sniff out serious health problems 3
ZOOM IPGRunner Mini-cell from Invitrogen
Sold individually or included in the MasterAmp™ PCR Optimization Kit without ammonium sulfate. Includes dNTPs, buffer, and varying amounts of MgCl2 and the MasterAmp™ PCR Enhancer (with be
ICC Diluent Buffer 250 ml
UltraMount is formulated for coverslipping sections stained with alcohol soluble chromogens, such as Fast-Red or AEC. No heating is required prior to use. Coverslips may be removed by soaking in wate
Biology Products: